News

Filter

Aspen buys rights to an anti-coagulant product from Novartis

26-01-2015

Aspen Global Inc, a wholly-owned subsidiary of South Africa’s Aspen Holdings, has entered into an agreement…

Aspen Global IncAspen HoldingsHematologyMergers & AcquisitionsMono-EmbolexNovartisPharmaceutical

Avalon Ventures and GlaxoSmithKline launch two new companies

23-09-2014

Avalon Ventures today announced the launch of two new companies formed through its collaboration with…

Avalon VenturesFinancialGlaxoSmithKlineHematologyMergers & AcquisitionsPharmaceuticalRare diseasesSilarus TherapeuticsThyritope Biosciences

Strides Arcolab acquires Raricap and Indian branded generic business of Bafna Pharma

22-07-2014

In a second acquisition this month, India’s Strides Arcolab has entered into an agreement with Bafna…

BafnaBafna PharmaBiopharmaceuticalBusiness FinanceCompanies based in BangaloreGenericsHealth Medical PharmaHematologyIndiaMergers & AcquisitionsRaricapStrides Arcolab

Baxter buys AesRx, gaining rights to investigational SCD drug

Baxter buys AesRx, gaining rights to investigational SCD drug

10-07-2014

US drugmaker Baxter International said yesterday that it has acquired AesRx, a private US biopharmaceutical…

Aes-103AesRxBaxter InternationalBiotechnologyHematologyMergers & AcquisitionsRare diseasesUSA

Baxter to acquire Chatham Therapeutics for $70 million

03-04-2014

USA-based Baxter International says it has agreed to acquire Chatham Therapeutics, a private biotechnology…

Baxter InternationalBiotechnologyChatham TherapeuticsHematologyMergers & Acquisitions

Galena Biopharma acquires Mills Pharmaceuticals

14-01-2014

US drugmaker Galena Biopharma revealed that it has acquired Mills Pharmaceuticals, which has the worldwide…

AnagrelideGalena BioPharmaHematologyMergers & AcquisitionsMills PharmaceuticalsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top